Photo from wikipedia
The rapid provision of blood products is life‐saving for patients with massive hemorrhage. Ideally, RhD‐negative blood products would be supplied to a woman of childbearing potential whose Rh type is… Click to show full abstract
The rapid provision of blood products is life‐saving for patients with massive hemorrhage. Ideally, RhD‐negative blood products would be supplied to a woman of childbearing potential whose Rh type is unknown due to the risk of D‐alloimmunization and the potential for hemolytic disease of the fetus and newborn to occur if RhD‐positive blood products are transfused. Therefore, there is a need for a test that rapidly determines her RhD type. This study compared the RhD type determined using a rapid ABO and RhD test to the RhD type determined by an immunohematology reference laboratory.